Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-1-31
pubmed:abstractText
During productive infection, human cytomegalovirus (HCMV) UL44 transcription initiates at three distinct start sites that are differentially regulated. Two of the start sites, the distal and the proximal, are active at early times, whereas the middle start site is active only at late times after infection. The UL44 early viral gene product is essential for viral DNA synthesis. The UL44 gene product from the late viral promoter affects primarily viral gene expression at late times after infection rather than viral DNA synthesis (H. Isomura, M. F. Stinski, A. Kudoh, S. Nakayama, S. Iwahori, Y. Sato, and T. Tsurumi, J. Virol. 81:6197, 2007). The UL44 early viral promoters have a canonical TATA sequence, "TATAA." In contrast, the UL44 late viral promoter has a noncanonical TATA sequence. Using recombinant viruses, we found that the noncanonical TATA sequence is required for the accumulation of late viral transcripts. The GC boxes that surround the middle TATA element did not affect the kinetics or the start site of UL44 late transcription. Replacement of the distal TATA element with a noncanonical TATA sequence did not affect the kinetics of transcription or the transcription start site, but it did induce an alternative transcript at late times after infection. The data indicate that a noncanonical TATA box is used at late times after HCMV infection.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-10644329, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-10882068, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-11381128, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-11402056, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-11739696, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-11960008, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-12610136, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-12651739, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-1318399, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-14519856, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-14623981, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-15542631, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-16014922, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-1654370, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-1656103, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-1658363, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-16645617, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-16772290, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-16916456, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-17202222, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-17409154, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-209215, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-2535734, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-2538657, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-2833425, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-3005633, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-3041043, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-4705382, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-7745721, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-7856311, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-7884850, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-7926770, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-8230421, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-8386266, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-8537667, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-8627710, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-8995648, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-9049319, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-9388207, http://linkedlifedata.com/resource/pubmed/commentcorrection/18057245-9811691
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1098-5514
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
82
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1638-46
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Noncanonical TATA sequence in the UL44 late promoter of human cytomegalovirus is required for the accumulation of late viral transcripts.
pubmed:affiliation
Division of Virology, Aichi Cancer Center Research Institute, 1-1, Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan. hisomura@aichi-cc.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't
More...